Jim Prutow is an Operating Executive focused on the healthcare sector.
Mr. Prutow has over 30 years of healthcare experience as both an executive and consultant across many medtech, life sciences, and diagnostics companies. Mr. Prutow most recently served as a Senior Healthcare PE Partner at PwC and PRTM for the past 15 years, where he collaborated with Carlyle and other private equity sponsors on hundreds of diligences across the globe as well as supported portfolio company management teams on value creation initiatives that have yielded billions in incremental value.
Before PwC, Mr. Prutow spent time as an executive at a range of leading healthcare companies including Baxter, Dade Behring, Nanogen and GeneLogic.
Mr. Prutow currently serves on the Board of Directors of Carlyle portfolio company Corro Health.
Mr. Prutow earned his B.S. in both Genetics and Economics at University of California, Davis, his MBA from Golden Gate University and his JD from the University of San Diego School of Law.